You are here:Home-Chemical Inhibitors & Agonists-GPCR-Dopamine Receptor-BAK4-54
BAK4-54

Chemical Structure : BAK4-54

CAS No.: 1802038-48-7

BAK4-54 (BAK 4-54)

Catalog No.: PC-47104Not For Human Use, Lab Use Only.

BAK4-54 is a high affinity dopamine D3 receptor (D3R) antagonist/partial agonist withIC50 of 8.0 nM as full D3R antagonist, EC50 of 140 nM as partial D3R agonist.

Packing Price Stock Quantity
100 mg Get quote
250 mg Get quote
500 mg Get quote
1 g Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC)

Biological Activity

BAK4-54 is a high affinity dopamine D3 receptor (D3R) antagonist/partial agonist withIC50 of 8.0 nM as full D3R antagonist, EC50 of 140 nM as partial D3R agonist.
BAK4-54 (0.4-10 mg/kg, i.p.) dose-dependently decreased oxycodone self-administration, and shifted the oxycodone dose-response curve downward in rats.
BAK4-54 facilitated extinction and inhibited oxycodone-induced reinstatement of drug-seeking behavior.
BAK4-54 also dose-dependently decreased oxycodone-enhanced locomotor activity.

Physicochemical Properties

M.Wt 426.564
Formula C27H30N4O
Appearance Solid
CAS No.
Storage
Solide Powder
-20°C 12 Months; 4°C 6 Months
In Solvent
-80°C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

N-(4-(4-(Naphthalen-1-yl)piperazin-1-yl)butyl)-1H-indole-2-carboxamide

References

1. Zhi-Bing You, et al. Neuropharmacology. 2017 Nov;126:190-199.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: